Index by author

01 July 2009; volume 34, issue 1

A

  1. Adams, H. R.

    1. Plumb, J. et al "Increased T-regulatory cells within lymphocyte follicles in moderate COPD." European Respiratory Journal 34.1 (2009): 89-94. Web. 23 Oct. 2019.

  2. Adner, M.

    1. Swedin, L. et al "Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice." European Respiratory Journal 34.1 (2009): 200-208. Web. 23 Oct. 2019.

  3. Akagi, T.

    1. Harada, T. et al "Histological findings of the computed tomography halo in pulmonary sarcoidosis." European Respiratory Journal 34.1 (2009): 281-283. Web. 23 Oct. 2019.

  4. Alfaham, M.

    1. Teo, S. S. S. et al "An evaluation of the completeness of reporting of childhood tuberculosis." European Respiratory Journal 34.1 (2009): 176-179. Web. 23 Oct. 2019.

  5. Ameille, J.

    1. Paris, C. et al "Pleural plaques and asbestosis: dose– and time–response relationships based on HRCT data." European Respiratory Journal 34.1 (2009): 72-79. Web. 23 Oct. 2019.

  6. Aubourg, F.

    1. Hubert, D. et al "Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments." European Respiratory Journal 34.1 (2009): 117-124. Web. 23 Oct. 2019.

B

  1. Barnes, K. C.

    1. Hansel, N. N. et al "Leptin receptor polymorphisms and lung function decline in COPD." European Respiratory Journal 34.1 (2009): 103-110. Web. 23 Oct. 2019.

  2. Barnes, P. J.

    1. Suissa, S., and P. J. Barnes. "Inhaled corticosteroids in COPD: the case against." European Respiratory Journal 34.1 (2009): 13-16. Web. 23 Oct. 2019.

  3. Barnier, A.

    1. Barnier, A. et al "Improvement of HIV-related pulmonary hypertension after the introduction of an antiretroviral therapy." European Respiratory Journal 34.1 (2009): 277-278. Web. 23 Oct. 2019.

  4. Beaty, T. H.

    1. Hansel, N. N. et al "Leptin receptor polymorphisms and lung function decline in COPD." European Respiratory Journal 34.1 (2009): 103-110. Web. 23 Oct. 2019.

  5. Bentley, A.

    1. Plumb, J. et al "Increased T-regulatory cells within lymphocyte follicles in moderate COPD." European Respiratory Journal 34.1 (2009): 89-94. Web. 23 Oct. 2019.

  6. Bolliger, C. T.

    1. Brunelli, A. et al "ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)." European Respiratory Journal 34.1 (2009): 17-41. Web. 23 Oct. 2019.

  7. Bonsignore, M. R.

    1. Lévy, P., M. R. Bonsignore, and J. Eckel. "Sleep, sleep-disordered breathing and metabolic consequences." European Respiratory Journal 34.1 (2009): 243-260. Web. 23 Oct. 2019.

  8. Borton, E. K.

    1. Lockey, J. E. et al "Airway obstruction related to diacetyl exposure at microwave popcorn production facilities." European Respiratory Journal 34.1 (2009): 63-71. Web. 23 Oct. 2019.

  9. Bos, I. S. T.

    1. Maarsingh, H. et al "l-Arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction." European Respiratory Journal 34.1 (2009): 191-199. Web. 23 Oct. 2019.

  10. Bossenga, B. E.

    1. Maarsingh, H. et al "l-Arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction." European Respiratory Journal 34.1 (2009): 191-199. Web. 23 Oct. 2019.

  11. Bracke, K. R.

    1. Brusselle, G. G. et al "Lymphoid follicles in (very) severe COPD: beneficial or harmful?." European Respiratory Journal 34.1 (2009): 219-230. Web. 23 Oct. 2019.

  12. Brandsma, C-A.

    1. Brusselle, G. G. et al "Lymphoid follicles in (very) severe COPD: beneficial or harmful?." European Respiratory Journal 34.1 (2009): 219-230. Web. 23 Oct. 2019.

  13. Brochard, P.

    1. Paris, C. et al "Pleural plaques and asbestosis: dose– and time–response relationships based on HRCT data." European Respiratory Journal 34.1 (2009): 72-79. Web. 23 Oct. 2019.

  14. Brüggen, H.

    1. Griese, M., and H. Brüggen. "Intravenous α1-antitrypsin in a child with deficiency and severe lung disease." European Respiratory Journal 34.1 (2009): 278-279. Web. 23 Oct. 2019.

  15. Brunelli, A.

    1. Brunelli, A. et al "ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)." European Respiratory Journal 34.1 (2009): 17-41. Web. 23 Oct. 2019.

  16. Brusasco, V.

    1. Dinh-Xuan, A. T., and V. Brusasco. "Refining the changes. Or, how to modify the shape, not the spirit." European Respiratory Journal 34.1 (2009): 1. Web. 23 Oct. 2019.

  17. Brusselle, G. G.

    1. Brusselle, G. G. et al "Lymphoid follicles in (very) severe COPD: beneficial or harmful?." European Respiratory Journal 34.1 (2009): 219-230. Web. 23 Oct. 2019.

  18. Bukovskis, M.

    1. Isajevs, S. et al " From the authors: ." European Respiratory Journal 34.1 (2009): 285-286. Web. 23 Oct. 2019.

C

  1. Cain, K. P.

    1. Dravniece, G. et al "Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis." European Respiratory Journal 34.1 (2009): 180-183. Web. 23 Oct. 2019.

  2. Calverley, P.

    1. Postma, D. S., and P. Calverley. "Inhaled corticosteroids in COPD: a case in favour." European Respiratory Journal 34.1 (2009): 10-12. Web. 23 Oct. 2019.

  3. Casanova, C.

    1. de Torres, J. P., C. Casanova, and B. R. Celli. " From the authors: ." European Respiratory Journal 34.1 (2009): 289. Web. 23 Oct. 2019.

  4. Celli, B. R.

    1. de Torres, J. P., C. Casanova, and B. R. Celli. " From the authors: ." European Respiratory Journal 34.1 (2009): 289. Web. 23 Oct. 2019.

  5. Charloux, A.

    1. Brunelli, A. et al "ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)." European Respiratory Journal 34.1 (2009): 17-41. Web. 23 Oct. 2019.

  6. Chen, C.

    1. Wang, Z. et al "Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?." European Respiratory Journal 34.1 (2009): 145-155. Web. 23 Oct. 2019.

  7. Clark, J.

    1. Teo, S. S. S. et al "An evaluation of the completeness of reporting of childhood tuberculosis." European Respiratory Journal 34.1 (2009): 176-179. Web. 23 Oct. 2019.

  8. Clément, A.

    1. Hubert, D. et al "Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments." European Respiratory Journal 34.1 (2009): 117-124. Web. 23 Oct. 2019.

  9. Clini, E. M.

    1. Brunelli, A. et al "ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)." European Respiratory Journal 34.1 (2009): 17-41. Web. 23 Oct. 2019.

  10. Connett, J.

    1. Hansel, N. N. et al "Leptin receptor polymorphisms and lung function decline in COPD." European Respiratory Journal 34.1 (2009): 103-110. Web. 23 Oct. 2019.

  11. Conso, F.

    1. Paris, C. et al "Pleural plaques and asbestosis: dose– and time–response relationships based on HRCT data." European Respiratory Journal 34.1 (2009): 72-79. Web. 23 Oct. 2019.

  12. Cornwall, S.

    1. Jackaman, C. et al "Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells." European Respiratory Journal 34.1 (2009): 162-175. Web. 23 Oct. 2019.

  13. Corral, J.

    1. Masa, J. F. et al "Apnoeic and obstructive nonapnoeic sleep respiratory events." European Respiratory Journal 34.1 (2009): 156-161. Web. 23 Oct. 2019.

  14. Cosio, B. G.

    1. Cosio, B. G., and J. B. Soriano. "Theophylline again? Reasons for believing." European Respiratory Journal 34.1 (2009): 5-6. Web. 23 Oct. 2019.

D

  1. d/o Kwajah M.M, S.

    1. Wang, Z. et al "Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?." European Respiratory Journal 34.1 (2009): 145-155. Web. 23 Oct. 2019.

  2. Dahlén, S-E.

    1. Swedin, L. et al "Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice." European Respiratory Journal 34.1 (2009): 200-208. Web. 23 Oct. 2019.

  3. Dautzenberg, B.

    1. Fernández, E. et al "Second-hand smoke exposure in a sample of European hospitals." European Respiratory Journal 34.1 (2009): 111-116. Web. 23 Oct. 2019.

  4. Degano, B.

    1. Degano, B. et al "Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients." European Respiratory Journal 34.1 (2009): 138-144. Web. 23 Oct. 2019.

  5. Delclaux, C.

    1. Hubert, D. et al "Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments." European Respiratory Journal 34.1 (2009): 117-124. Web. 23 Oct. 2019.

  6. Demoor, T.

    1. Brusselle, G. G. et al "Lymphoid follicles in (very) severe COPD: beneficial or harmful?." European Respiratory Journal 34.1 (2009): 219-230. Web. 23 Oct. 2019.

  7. Deng, J-M.

    1. Liu, G-N. et al "Epithelial neutrophil-activating peptide-78 recruits neutrophils into pleural effusion." European Respiratory Journal 34.1 (2009): 184-190. Web. 23 Oct. 2019.

  8. De Ruysscher, D.

    1. Brunelli, A. et al "ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)." European Respiratory Journal 34.1 (2009): 17-41. Web. 23 Oct. 2019.

  9. de Torres, J. P.

    1. de Torres, J. P., C. Casanova, and B. R. Celli. " From the authors: ." European Respiratory Journal 34.1 (2009): 289. Web. 23 Oct. 2019.

  10. Dewilde, J.

    1. Barnier, A. et al "Improvement of HIV-related pulmonary hypertension after the introduction of an antiretroviral therapy." European Respiratory Journal 34.1 (2009): 277-278. Web. 23 Oct. 2019.

  11. Dinh-Xuan, A. T.

    1. Dinh-Xuan, A. T., and V. Brusasco. "Refining the changes. Or, how to modify the shape, not the spirit." European Respiratory Journal 34.1 (2009): 1. Web. 23 Oct. 2019.
    2. Hubert, D. et al "Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments." European Respiratory Journal 34.1 (2009): 117-124. Web. 23 Oct. 2019.

  12. Disdier, C.

    1. Masa, J. F. et al "Apnoeic and obstructive nonapnoeic sleep respiratory events." European Respiratory Journal 34.1 (2009): 156-161. Web. 23 Oct. 2019.

  13. Domagala-Kulawik, J.

    1. Domagala-Kulawik, J., and M. Maskey-Warzecowska. "T-regulatory cells in COPD or tumour environment." European Respiratory Journal 34.1 (2009): 284. Web. 23 Oct. 2019.

  14. Dravniece, G.

    1. Dravniece, G. et al "Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis." European Respiratory Journal 34.1 (2009): 180-183. Web. 23 Oct. 2019.

E

  1. Eastwood, P. R.

    1. Williamson, J. P. et al "Quantifying tracheobronchial tree dimensions: methods, limitations and emerging techniques." European Respiratory Journal 34.1 (2009): 42-55. Web. 23 Oct. 2019.

  2. Eckel, J.

    1. Lévy, P., M. R. Bonsignore, and J. Eckel. "Sleep, sleep-disordered breathing and metabolic consequences." European Respiratory Journal 34.1 (2009): 243-260. Web. 23 Oct. 2019.

  3. Edwards, L. D.

    1. Lomas, D. A. et al "Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD." European Respiratory Journal 34.1 (2009): 95-102. Web. 23 Oct. 2019.

  4. Evans, M. R.

    1. Teo, S. S. S. et al "An evaluation of the completeness of reporting of childhood tuberculosis." European Respiratory Journal 34.1 (2009): 176-179. Web. 23 Oct. 2019.

  5. Ewert, R.

    1. Hoeper, M. M. et al "Long-term outcome with intravenous iloprost in pulmonary arterial hypertension." European Respiratory Journal 34.1 (2009): 132-137. Web. 23 Oct. 2019.
    2. Koch, B. et al " From the authors: ." European Respiratory Journal 34.1 (2009): 287-288. Web. 23 Oct. 2019.

F

  1. Faivre-Finn, C.

    1. Brunelli, A. et al "ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)." European Respiratory Journal 34.1 (2009): 17-41. Web. 23 Oct. 2019.

  2. Fauroux, B.

    1. Hubert, D. et al "Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments." European Respiratory Journal 34.1 (2009): 117-124. Web. 23 Oct. 2019.

  3. Ferguson, M. K.

    1. Brunelli, A. et al "ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)." European Respiratory Journal 34.1 (2009): 17-41. Web. 23 Oct. 2019.

  4. Fernández, E.

    1. Fernández, E. et al "Second-hand smoke exposure in a sample of European hospitals." European Respiratory Journal 34.1 (2009): 111-116. Web. 23 Oct. 2019.

  5. Finger, S. N.

    1. Wang, Z. et al "Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?." European Respiratory Journal 34.1 (2009): 145-155. Web. 23 Oct. 2019.

  6. Frachon, I.

    1. Barnier, A. et al "Improvement of HIV-related pulmonary hypertension after the introduction of an antiretroviral therapy." European Respiratory Journal 34.1 (2009): 277-278. Web. 23 Oct. 2019.

  7. Fu, M.

    1. Fernández, E. et al "Second-hand smoke exposure in a sample of European hospitals." European Respiratory Journal 34.1 (2009): 111-116. Web. 23 Oct. 2019.

  8. Fujita, M.

    1. Harada, T. et al "Histological findings of the computed tomography halo in pulmonary sarcoidosis." European Respiratory Journal 34.1 (2009): 281-283. Web. 23 Oct. 2019.

G

  1. Galiè, N.

    1. Peacock, A. J. et al "End-points and clinical trial design in pulmonary arterial hypertension: have we made progress?." European Respiratory Journal 34.1 (2009): 231-242. Web. 23 Oct. 2019.

  2. Gall, H.

    1. Hoeper, M. M. et al "Long-term outcome with intravenous iloprost in pulmonary arterial hypertension." European Respiratory Journal 34.1 (2009): 132-137. Web. 23 Oct. 2019.

  3. Gao, L.

    1. Hansel, N. N. et al "Leptin receptor polymorphisms and lung function decline in COPD." European Respiratory Journal 34.1 (2009): 103-110. Web. 23 Oct. 2019.

  4. Gerritsen, J.

    1. Gerritsen, J.. "The Brussels Declaration." European Respiratory Journal 34.1 (2009): 290. Web. 23 Oct. 2019.

  5. Ghofrani, H. A.

    1. Hoeper, M. M. et al "Long-term outcome with intravenous iloprost in pulmonary arterial hypertension." European Respiratory Journal 34.1 (2009): 132-137. Web. 23 Oct. 2019.

  6. Gläser, S.

    1. Koch, B. et al " From the authors: ." European Respiratory Journal 34.1 (2009): 287-288. Web. 23 Oct. 2019.

  7. Goldman, L.

    1. Brunelli, A. et al "ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)." European Respiratory Journal 34.1 (2009): 17-41. Web. 23 Oct. 2019.

  8. Golpon, H.

    1. Hoeper, M. M. et al "Long-term outcome with intravenous iloprost in pulmonary arterial hypertension." European Respiratory Journal 34.1 (2009): 132-137. Web. 23 Oct. 2019.

  9. Gordjusina, V.

    1. Isajevs, S. et al " From the authors: ." European Respiratory Journal 34.1 (2009): 285-286. Web. 23 Oct. 2019.

  10. Graat-Verboom, L.

    1. Graat-Verboom, L. et al "Current status of research on osteoporosis in COPD: a systematic review." European Respiratory Journal 34.1 (2009): 209-218. Web. 23 Oct. 2019.

  11. Grant, A. V.

    1. Hansel, N. N. et al "Leptin receptor polymorphisms and lung function decline in COPD." European Respiratory Journal 34.1 (2009): 103-110. Web. 23 Oct. 2019.

  12. Griese, M.

    1. Griese, M., and H. Brüggen. "Intravenous α1-antitrypsin in a child with deficiency and severe lung disease." European Respiratory Journal 34.1 (2009): 278-279. Web. 23 Oct. 2019.

  13. Groenwold, R. H. H.

    1. Groenwold, R. H. H., A. W. Hoes, and E. Hak. "Impact of influenza vaccination on mortality risk among the elderly." European Respiratory Journal 34.1 (2009): 56-62. Web. 23 Oct. 2019.

  14. Gut-Gobert, C.

    1. Barnier, A. et al "Improvement of HIV-related pulmonary hypertension after the introduction of an antiretroviral therapy." European Respiratory Journal 34.1 (2009): 277-278. Web. 23 Oct. 2019.

  15. Gyulai, N.

    1. Horváth, I. et al "Exhaled biomarkers in lung cancer." European Respiratory Journal 34.1 (2009): 261-275. Web. 23 Oct. 2019.

H

  1. Hak, E.

    1. Groenwold, R. H. H., A. W. Hoes, and E. Hak. "Impact of influenza vaccination on mortality risk among the elderly." European Respiratory Journal 34.1 (2009): 56-62. Web. 23 Oct. 2019.

  2. Halank, M.

    1. Hoeper, M. M. et al "Long-term outcome with intravenous iloprost in pulmonary arterial hypertension." European Respiratory Journal 34.1 (2009): 132-137. Web. 23 Oct. 2019.

  3. Hansel, N. N.

    1. Hansel, N. N. et al "Leptin receptor polymorphisms and lung function decline in COPD." European Respiratory Journal 34.1 (2009): 103-110. Web. 23 Oct. 2019.

  4. Harada, T.

    1. Harada, T. et al "Histological findings of the computed tomography halo in pulmonary sarcoidosis." European Respiratory Journal 34.1 (2009): 281-283. Web. 23 Oct. 2019.

  5. Hayward, A.

    1. Teo, S. S. S. et al "An evaluation of the completeness of reporting of childhood tuberculosis." European Respiratory Journal 34.1 (2009): 176-179. Web. 23 Oct. 2019.

  6. Hervé, P.

    1. Degano, B. et al "Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients." European Respiratory Journal 34.1 (2009): 138-144. Web. 23 Oct. 2019.

  7. Hilbert, T. J.

    1. Lockey, J. E. et al "Airway obstruction related to diacetyl exposure at microwave popcorn production facilities." European Respiratory Journal 34.1 (2009): 63-71. Web. 23 Oct. 2019.

  8. Hill, A. T.

    1. Murray, M. P. et al "Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis." European Respiratory Journal 34.1 (2009): 125-131. Web. 23 Oct. 2019.

  9. Hillman, D. R.

    1. Williamson, J. P. et al "Quantifying tracheobronchial tree dimensions: methods, limitations and emerging techniques." European Respiratory Journal 34.1 (2009): 42-55. Web. 23 Oct. 2019.

  10. Hjoberg, J.

    1. Swedin, L. et al "Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice." European Respiratory Journal 34.1 (2009): 200-208. Web. 23 Oct. 2019.

  11. Hoeper, M. M.

    1. Hoeper, M. M. et al "Long-term outcome with intravenous iloprost in pulmonary arterial hypertension." European Respiratory Journal 34.1 (2009): 132-137. Web. 23 Oct. 2019.
    2. Spiekermann, S., K. Schenk, and M. M. Hoeper. "Increased xanthine oxidase activity in idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.1 (2009): 276. Web. 23 Oct. 2019.

  12. Hoes, A. W.

    1. Groenwold, R. H. H., A. W. Hoes, and E. Hak. "Impact of influenza vaccination on mortality risk among the elderly." European Respiratory Journal 34.1 (2009): 56-62. Web. 23 Oct. 2019.

  13. Holtz, T. H.

    1. Dravniece, G. et al "Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis." European Respiratory Journal 34.1 (2009): 180-183. Web. 23 Oct. 2019.

  14. Horstman, D. H.

    1. Lomas, D. A. et al "Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD." European Respiratory Journal 34.1 (2009): 95-102. Web. 23 Oct. 2019.

  15. Horváth, I.

    1. Horváth, I. et al "Exhaled biomarkers in lung cancer." European Respiratory Journal 34.1 (2009): 261-275. Web. 23 Oct. 2019.

  16. Huang, H-Q.

    1. Liu, G-N. et al "Epithelial neutrophil-activating peptide-78 recruits neutrophils into pleural effusion." European Respiratory Journal 34.1 (2009): 184-190. Web. 23 Oct. 2019.

  17. Huber, R. M.

    1. Brunelli, A. et al "ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)." European Respiratory Journal 34.1 (2009): 17-41. Web. 23 Oct. 2019.

  18. Hubert, D.

    1. Hubert, D. et al "Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments." European Respiratory Journal 34.1 (2009): 117-124. Web. 23 Oct. 2019.

I

  1. Invernizzi, G.

    1. Fernández, E. et al "Second-hand smoke exposure in a sample of European hospitals." European Respiratory Journal 34.1 (2009): 111-116. Web. 23 Oct. 2019.

  2. Isajevs, S.

    1. Isajevs, S. et al " From the authors: ." European Respiratory Journal 34.1 (2009): 285-286. Web. 23 Oct. 2019.

J

  1. Jackaman, C.

    1. Jackaman, C. et al "Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells." European Respiratory Journal 34.1 (2009): 162-175. Web. 23 Oct. 2019.

  2. James, A. L.

    1. Williamson, J. P. et al "Quantifying tracheobronchial tree dimensions: methods, limitations and emerging techniques." European Respiratory Journal 34.1 (2009): 42-55. Web. 23 Oct. 2019.

  3. Jobic, Y.

    1. Barnier, A. et al "Improvement of HIV-related pulmonary hypertension after the introduction of an antiretroviral therapy." European Respiratory Journal 34.1 (2009): 277-278. Web. 23 Oct. 2019.

  4. Jonasson, S.

    1. Swedin, L. et al "Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice." European Respiratory Journal 34.1 (2009): 200-208. Web. 23 Oct. 2019.

  5. Jung, M.

    1. Wang, Z. et al "Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?." European Respiratory Journal 34.1 (2009): 145-155. Web. 23 Oct. 2019.

K

  1. Kamar, N.

    1. Degano, B. et al "Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients." European Respiratory Journal 34.1 (2009): 138-144. Web. 23 Oct. 2019.

  2. Kanada, Y.

    1. Ohta, K. et al "Evaluation of swallowing function by two screening tests in primary COPD." European Respiratory Journal 34.1 (2009): 280-281. Web. 23 Oct. 2019.

  3. Koch, B.

    1. Koch, B. et al " From the authors: ." European Respiratory Journal 34.1 (2009): 287-288. Web. 23 Oct. 2019.

  4. Kollai, M.

    1. Horváth, I. et al "Exhaled biomarkers in lung cancer." European Respiratory Journal 34.1 (2009): 261-275. Web. 23 Oct. 2019.

  5. Kopeika, U.

    1. Isajevs, S. et al " From the authors: ." European Respiratory Journal 34.1 (2009): 285-286. Web. 23 Oct. 2019.

  6. Kratovska, A.

    1. Isajevs, S. et al " From the authors: ." European Respiratory Journal 34.1 (2009): 285-286. Web. 23 Oct. 2019.

L

  1. Lahm, T.

    1. Lahm, T.. "Sex differences in COPD." European Respiratory Journal 34.1 (2009): 288-289. Web. 23 Oct. 2019.

  2. Lareu, R. R.

    1. Wang, Z. et al "Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?." European Respiratory Journal 34.1 (2009): 145-155. Web. 23 Oct. 2019.

  3. Larsson, K.

    1. Sundblad, B-M. et al "Repeated exposure to organic material alters inflammatory and physiological airway responses." European Respiratory Journal 34.1 (2009): 80-88. Web. 23 Oct. 2019.

  4. Lázár, Z.

    1. Horváth, I. et al "Exhaled biomarkers in lung cancer." European Respiratory Journal 34.1 (2009): 261-275. Web. 23 Oct. 2019.

  5. Leimane, V.

    1. Dravniece, G. et al "Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis." European Respiratory Journal 34.1 (2009): 180-183. Web. 23 Oct. 2019.

  6. LeMasters, G. K.

    1. Lockey, J. E. et al "Airway obstruction related to diacetyl exposure at microwave popcorn production facilities." European Respiratory Journal 34.1 (2009): 63-71. Web. 23 Oct. 2019.

  7. Lenoir, G.

    1. Hubert, D. et al "Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments." European Respiratory Journal 34.1 (2009): 117-124. Web. 23 Oct. 2019.

  8. Leroyer, C.

    1. Barnier, A. et al "Improvement of HIV-related pulmonary hypertension after the introduction of an antiretroviral therapy." European Respiratory Journal 34.1 (2009): 277-278. Web. 23 Oct. 2019.

  9. Letourneux, M.

    1. Paris, C. et al "Pleural plaques and asbestosis: dose– and time–response relationships based on HRCT data." European Respiratory Journal 34.1 (2009): 72-79. Web. 23 Oct. 2019.

  10. Levin, L. P.

    1. Lockey, J. E. et al "Airway obstruction related to diacetyl exposure at microwave popcorn production facilities." European Respiratory Journal 34.1 (2009): 63-71. Web. 23 Oct. 2019.

  11. Lévy, P.

    1. Lévy, P., M. R. Bonsignore, and J. Eckel. "Sleep, sleep-disordered breathing and metabolic consequences." European Respiratory Journal 34.1 (2009): 243-260. Web. 23 Oct. 2019.

  12. Lew, A. M.

    1. Jackaman, C. et al "Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells." European Respiratory Journal 34.1 (2009): 162-175. Web. 23 Oct. 2019.

  13. Liang, Q-L.

    1. Liu, G-N. et al "Epithelial neutrophil-activating peptide-78 recruits neutrophils into pleural effusion." European Respiratory Journal 34.1 (2009): 184-190. Web. 23 Oct. 2019.

  14. Licker, M.

    1. Brunelli, A. et al "ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)." European Respiratory Journal 34.1 (2009): 17-41. Web. 23 Oct. 2019.

  15. Liu, G-N.

    1. Liu, G-N. et al "Epithelial neutrophil-activating peptide-78 recruits neutrophils into pleural effusion." European Respiratory Journal 34.1 (2009): 184-190. Web. 23 Oct. 2019.

  16. Locantore, N. W.

    1. Lomas, D. A. et al "Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD." European Respiratory Journal 34.1 (2009): 95-102. Web. 23 Oct. 2019.

  17. Lockey, J. E.

    1. Lockey, J. E. et al "Airway obstruction related to diacetyl exposure at microwave popcorn production facilities." European Respiratory Journal 34.1 (2009): 63-71. Web. 23 Oct. 2019.

  18. Lomas, D. A.

    1. Lomas, D. A. et al "Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD." European Respiratory Journal 34.1 (2009): 95-102. Web. 23 Oct. 2019.

  19. López, M. J.

    1. Fernández, E. et al "Second-hand smoke exposure in a sample of European hospitals." European Respiratory Journal 34.1 (2009): 111-116. Web. 23 Oct. 2019.

  20. Losonczy, G.

    1. Horváth, I. et al "Exhaled biomarkers in lung cancer." European Respiratory Journal 34.1 (2009): 261-275. Web. 23 Oct. 2019.

  21. Louis, B.

    1. Hubert, D. et al "Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments." European Respiratory Journal 34.1 (2009): 117-124. Web. 23 Oct. 2019.

  22. Lunde, R.

    1. Graat-Verboom, L. et al "Current status of research on osteoporosis in COPD: a systematic review." European Respiratory Journal 34.1 (2009): 209-218. Web. 23 Oct. 2019.

M

  1. Maarsingh, H.

    1. Maarsingh, H. et al "l-Arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction." European Respiratory Journal 34.1 (2009): 191-199. Web. 23 Oct. 2019.

  2. MacQuarrie, S.

    1. Murray, M. P. et al "Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis." European Respiratory Journal 34.1 (2009): 125-131. Web. 23 Oct. 2019.

  3. Mahut, B.

    1. Hubert, D. et al "Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments." European Respiratory Journal 34.1 (2009): 117-124. Web. 23 Oct. 2019.

  4. Martin, M. J.

    1. Masa, J. F. et al "Apnoeic and obstructive nonapnoeic sleep respiratory events." European Respiratory Journal 34.1 (2009): 156-161. Web. 23 Oct. 2019.

  5. Martínez, C.

    1. Fernández, E. et al "Second-hand smoke exposure in a sample of European hospitals." European Respiratory Journal 34.1 (2009): 111-116. Web. 23 Oct. 2019.

  6. Martínez-Sánchez, J. M.

    1. Fernández, E. et al "Second-hand smoke exposure in a sample of European hospitals." European Respiratory Journal 34.1 (2009): 111-116. Web. 23 Oct. 2019.

  7. Masa, J. F.

    1. Masa, J. F. et al "Apnoeic and obstructive nonapnoeic sleep respiratory events." European Respiratory Journal 34.1 (2009): 156-161. Web. 23 Oct. 2019.

  8. Maskey-Warzecowska, M.

    1. Domagala-Kulawik, J., and M. Maskey-Warzecowska. "T-regulatory cells in COPD or tumour environment." European Respiratory Journal 34.1 (2009): 284. Web. 23 Oct. 2019.

  9. Mathias, R. A.

    1. Hansel, N. N. et al "Leptin receptor polymorphisms and lung function decline in COPD." European Respiratory Journal 34.1 (2009): 103-110. Web. 23 Oct. 2019.

  10. Matsumoto, T.

    1. Harada, T. et al "Histological findings of the computed tomography halo in pulmonary sarcoidosis." European Respiratory Journal 34.1 (2009): 281-283. Web. 23 Oct. 2019.

  11. McKay, R. T.

    1. Lockey, J. E. et al "Airway obstruction related to diacetyl exposure at microwave popcorn production facilities." European Respiratory Journal 34.1 (2009): 63-71. Web. 23 Oct. 2019.

  12. Meurs, H.

    1. Maarsingh, H. et al "l-Arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction." European Respiratory Journal 34.1 (2009): 191-199. Web. 23 Oct. 2019.

  13. Miller, B. E.

    1. Lomas, D. A. et al "Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD." European Respiratory Journal 34.1 (2009): 95-102. Web. 23 Oct. 2019.

  14. Minatani, S.

    1. Ohta, K. et al "Evaluation of swallowing function by two screening tests in primary COPD." European Respiratory Journal 34.1 (2009): 280-281. Web. 23 Oct. 2019.

  15. Mittaine, M.

    1. Degano, B. et al "Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients." European Respiratory Journal 34.1 (2009): 138-144. Web. 23 Oct. 2019.

  16. Montserrat, J. M.

    1. Masa, J. F. et al "Apnoeic and obstructive nonapnoeic sleep respiratory events." European Respiratory Journal 34.1 (2009): 156-161. Web. 23 Oct. 2019.

  17. Moore-Gillon, J.

    1. Teo, S. S. S. et al "An evaluation of the completeness of reporting of childhood tuberculosis." European Respiratory Journal 34.1 (2009): 176-179. Web. 23 Oct. 2019.

  18. Mota, M.

    1. Masa, J. F. et al "Apnoeic and obstructive nonapnoeic sleep respiratory events." European Respiratory Journal 34.1 (2009): 156-161. Web. 23 Oct. 2019.

  19. Murata, K.

    1. Ohta, K. et al "Evaluation of swallowing function by two screening tests in primary COPD." European Respiratory Journal 34.1 (2009): 280-281. Web. 23 Oct. 2019.

  20. Murray, M. P.

    1. Murray, M. P. et al "Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis." European Respiratory Journal 34.1 (2009): 125-131. Web. 23 Oct. 2019.

N

  1. Nabeshima, K.

    1. Harada, T. et al "Histological findings of the computed tomography halo in pulmonary sarcoidosis." European Respiratory Journal 34.1 (2009): 281-283. Web. 23 Oct. 2019.

  2. Naeije, R.

    1. Peacock, A. J. et al "End-points and clinical trial design in pulmonary arterial hypertension: have we made progress?." European Respiratory Journal 34.1 (2009): 231-242. Web. 23 Oct. 2019.

  3. Nebot, M.

    1. Fernández, E. et al "Second-hand smoke exposure in a sample of European hospitals." European Respiratory Journal 34.1 (2009): 111-116. Web. 23 Oct. 2019.

  4. Neder, J. A.

    1. Neder, J. A.. "On the issue of exercise normalcy." European Respiratory Journal 34.1 (2009): 286-287. Web. 23 Oct. 2019.

  5. Neimert-Andersson, T.

    1. Swedin, L. et al "Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice." European Respiratory Journal 34.1 (2009): 200-208. Web. 23 Oct. 2019.

  6. Nelson, D. J.

    1. Jackaman, C. et al "Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells." European Respiratory Journal 34.1 (2009): 162-175. Web. 23 Oct. 2019.

  7. Neptune, E. R.

    1. Hansel, N. N. et al "Leptin receptor polymorphisms and lung function decline in COPD." European Respiratory Journal 34.1 (2009): 103-110. Web. 23 Oct. 2019.

  8. Nickel, N.

    1. Hoeper, M. M. et al "Long-term outcome with intravenous iloprost in pulmonary arterial hypertension." European Respiratory Journal 34.1 (2009): 132-137. Web. 23 Oct. 2019.

  9. Novelli, V.

    1. Teo, S. S. S. et al "An evaluation of the completeness of reporting of childhood tuberculosis." European Respiratory Journal 34.1 (2009): 176-179. Web. 23 Oct. 2019.

O

  1. Ohta, K.

    1. Ohta, K. et al "Evaluation of swallowing function by two screening tests in primary COPD." European Respiratory Journal 34.1 (2009): 280-281. Web. 23 Oct. 2019.

  2. Olsson, K. M.

    1. Hoeper, M. M. et al "Long-term outcome with intravenous iloprost in pulmonary arterial hypertension." European Respiratory Journal 34.1 (2009): 132-137. Web. 23 Oct. 2019.

  3. Olsson, M.

    1. Sundblad, B-M. et al "Repeated exposure to organic material alters inflammatory and physiological airway responses." European Respiratory Journal 34.1 (2009): 80-88. Web. 23 Oct. 2019.

  4. Opitz, C.

    1. Hoeper, M. M. et al "Long-term outcome with intravenous iloprost in pulmonary arterial hypertension." European Respiratory Journal 34.1 (2009): 132-137. Web. 23 Oct. 2019.

  5. Ouranou, A.

    1. Fernández, E. et al "Second-hand smoke exposure in a sample of European hospitals." European Respiratory Journal 34.1 (2009): 111-116. Web. 23 Oct. 2019.

P

  1. Pairon, J. C.

    1. Paris, C. et al "Pleural plaques and asbestosis: dose– and time–response relationships based on HRCT data." European Respiratory Journal 34.1 (2009): 72-79. Web. 23 Oct. 2019.

  2. Palmberg, L.

    1. Sundblad, B-M. et al "Repeated exposure to organic material alters inflammatory and physiological airway responses." European Respiratory Journal 34.1 (2009): 80-88. Web. 23 Oct. 2019.

  3. Paris, C.

    1. Paris, C. et al "Pleural plaques and asbestosis: dose– and time–response relationships based on HRCT data." European Respiratory Journal 34.1 (2009): 72-79. Web. 23 Oct. 2019.

  4. Partridge, M. R.

    1. Smith, S. M., and M. R. Partridge. "Getting the rehabilitation message across: emerging barriers and positive health benefits." European Respiratory Journal 34.1 (2009): 2-4. Web. 23 Oct. 2019.

  5. Peacock, A. J.

    1. Peacock, A. J. et al "End-points and clinical trial design in pulmonary arterial hypertension: have we made progress?." European Respiratory Journal 34.1 (2009): 231-242. Web. 23 Oct. 2019.

  6. Pentland, J. L.

    1. Murray, M. P. et al "Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis." European Respiratory Journal 34.1 (2009): 125-131. Web. 23 Oct. 2019.

  7. Phillips, M. J.

    1. Williamson, J. P. et al "Quantifying tracheobronchial tree dimensions: methods, limitations and emerging techniques." European Respiratory Journal 34.1 (2009): 42-55. Web. 23 Oct. 2019.

  8. Plumb, J.

    1. Plumb, J. et al "Increased T-regulatory cells within lymphocyte follicles in moderate COPD." European Respiratory Journal 34.1 (2009): 89-94. Web. 23 Oct. 2019.

  9. Postma, D. S.

    1. Postma, D. S., and P. Calverley. "Inhaled corticosteroids in COPD: a case in favour." European Respiratory Journal 34.1 (2009): 10-12. Web. 23 Oct. 2019.

  10. Provencher, S.

    1. Provencher, S., and O. Sitbon. "Intravenous iloprost for pulmonary arterial hypertension: still waiting for evidence." European Respiratory Journal 34.1 (2009): 7-9. Web. 23 Oct. 2019.

Q

  1. Quinn, D.

    1. Teo, S. S. S. et al "An evaluation of the completeness of reporting of childhood tuberculosis." European Respiratory Journal 34.1 (2009): 176-179. Web. 23 Oct. 2019.

R

  1. Rafaels, N. M.

    1. Hansel, N. N. et al "Leptin receptor polymorphisms and lung function decline in COPD." European Respiratory Journal 34.1 (2009): 103-110. Web. 23 Oct. 2019.

  2. Raghunath, M.

    1. Wang, Z. et al "Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?." European Respiratory Journal 34.1 (2009): 145-155. Web. 23 Oct. 2019.

  3. Rami, J.

    1. Degano, B. et al "Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients." European Respiratory Journal 34.1 (2009): 138-144. Web. 23 Oct. 2019.

  4. Rice, C. H.

    1. Lockey, J. E. et al "Airway obstruction related to diacetyl exposure at microwave popcorn production facilities." European Respiratory Journal 34.1 (2009): 63-71. Web. 23 Oct. 2019.

  5. Riekstina, V.

    1. Dravniece, G. et al "Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis." European Respiratory Journal 34.1 (2009): 180-183. Web. 23 Oct. 2019.

  6. Riordan, A.

    1. Teo, S. S. S. et al "An evaluation of the completeness of reporting of childhood tuberculosis." European Respiratory Journal 34.1 (2009): 176-179. Web. 23 Oct. 2019.

  7. Rivière, D.

    1. Degano, B. et al "Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients." European Respiratory Journal 34.1 (2009): 138-144. Web. 23 Oct. 2019.

  8. Robinson, B. W. S.

    1. Jackaman, C. et al "Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells." European Respiratory Journal 34.1 (2009): 162-175. Web. 23 Oct. 2019.

  9. Rocco, G.

    1. Brunelli, A. et al "ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)." European Respiratory Journal 34.1 (2009): 17-41. Web. 23 Oct. 2019.

  10. Rostaing, L.

    1. Degano, B. et al "Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients." European Respiratory Journal 34.1 (2009): 138-144. Web. 23 Oct. 2019.

  11. Rubin, L.

    1. Peacock, A. J. et al "End-points and clinical trial design in pulmonary arterial hypertension: have we made progress?." European Respiratory Journal 34.1 (2009): 231-242. Web. 23 Oct. 2019.

  12. Rubio, M.

    1. Masa, J. F. et al "Apnoeic and obstructive nonapnoeic sleep respiratory events." European Respiratory Journal 34.1 (2009): 156-161. Web. 23 Oct. 2019.

  13. Ryan, P. H.

    1. Lockey, J. E. et al "Airway obstruction related to diacetyl exposure at microwave popcorn production facilities." European Respiratory Journal 34.1 (2009): 63-71. Web. 23 Oct. 2019.

  14. Ryrfeldt, Å.

    1. Swedin, L. et al "Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice." European Respiratory Journal 34.1 (2009): 200-208. Web. 23 Oct. 2019.

S

  1. Sako, S.

    1. Ohta, K. et al "Evaluation of swallowing function by two screening tests in primary COPD." European Respiratory Journal 34.1 (2009): 280-281. Web. 23 Oct. 2019.

  2. Sampson, D. D.

    1. Williamson, J. P. et al "Quantifying tracheobronchial tree dimensions: methods, limitations and emerging techniques." European Respiratory Journal 34.1 (2009): 42-55. Web. 23 Oct. 2019.

  3. Schäper, C.

    1. Koch, B. et al " From the authors: ." European Respiratory Journal 34.1 (2009): 287-288. Web. 23 Oct. 2019.

  4. Schenk, K.

    1. Spiekermann, S., K. Schenk, and M. M. Hoeper. "Increased xanthine oxidase activity in idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.1 (2009): 276. Web. 23 Oct. 2019.

  5. Schorle, E.

    1. Paris, C. et al "Pleural plaques and asbestosis: dose– and time–response relationships based on HRCT data." European Respiratory Journal 34.1 (2009): 72-79. Web. 23 Oct. 2019.

  6. Schwarz, H.

    1. Wang, Z. et al "Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?." European Respiratory Journal 34.1 (2009): 145-155. Web. 23 Oct. 2019.

  7. Sculier, J-P.

    1. Brunelli, A. et al "ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)." European Respiratory Journal 34.1 (2009): 17-41. Web. 23 Oct. 2019.

  8. Sermet, I.

    1. Hubert, D. et al "Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments." European Respiratory Journal 34.1 (2009): 117-124. Web. 23 Oct. 2019.

  9. Seyfarth, H. J.

    1. Hoeper, M. M. et al "Long-term outcome with intravenous iloprost in pulmonary arterial hypertension." European Respiratory Journal 34.1 (2009): 132-137. Web. 23 Oct. 2019.

  10. Sharland, M.

    1. Teo, S. S. S. et al "An evaluation of the completeness of reporting of childhood tuberculosis." European Respiratory Journal 34.1 (2009): 176-179. Web. 23 Oct. 2019.

  11. Shen, H-H.

    1. Liu, G-N. et al "Epithelial neutrophil-activating peptide-78 recruits neutrophils into pleural effusion." European Respiratory Journal 34.1 (2009): 184-190. Web. 23 Oct. 2019.

  12. Shi, H-Z.

    1. Liu, G-N. et al "Epithelial neutrophil-activating peptide-78 recruits neutrophils into pleural effusion." European Respiratory Journal 34.1 (2009): 184-190. Web. 23 Oct. 2019.

  13. Shingadia, D.

    1. Teo, S. S. S. et al "An evaluation of the completeness of reporting of childhood tuberculosis." European Respiratory Journal 34.1 (2009): 176-179. Web. 23 Oct. 2019.

  14. Silverman, E. K.

    1. Lomas, D. A. et al "Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD." European Respiratory Journal 34.1 (2009): 95-102. Web. 23 Oct. 2019.

  15. Singh, S. D.

    1. Plumb, J. et al "Increased T-regulatory cells within lymphocyte follicles in moderate COPD." European Respiratory Journal 34.1 (2009): 89-94. Web. 23 Oct. 2019.

  16. Sitbon, O.

    1. Provencher, S., and O. Sitbon. "Intravenous iloprost for pulmonary arterial hypertension: still waiting for evidence." European Respiratory Journal 34.1 (2009): 7-9. Web. 23 Oct. 2019.

  17. Smeenk, F. W. J. M.

    1. Graat-Verboom, L. et al "Current status of research on osteoporosis in COPD: a systematic review." European Respiratory Journal 34.1 (2009): 209-218. Web. 23 Oct. 2019.

  18. Smith, S. M.

    1. Smith, S. M., and M. R. Partridge. "Getting the rehabilitation message across: emerging barriers and positive health benefits." European Respiratory Journal 34.1 (2009): 2-4. Web. 23 Oct. 2019.

  19. Smyth, L. J. C.

    1. Plumb, J. et al "Increased T-regulatory cells within lymphocyte follicles in moderate COPD." European Respiratory Journal 34.1 (2009): 89-94. Web. 23 Oct. 2019.

  20. Sonnenberg, P.

    1. Teo, S. S. S. et al "An evaluation of the completeness of reporting of childhood tuberculosis." European Respiratory Journal 34.1 (2009): 176-179. Web. 23 Oct. 2019.

  21. Soriano, J. B.

    1. Cosio, B. G., and J. B. Soriano. "Theophylline again? Reasons for believing." European Respiratory Journal 34.1 (2009): 5-6. Web. 23 Oct. 2019.

  22. Spiekermann, S.

    1. Spiekermann, S., K. Schenk, and M. M. Hoeper. "Increased xanthine oxidase activity in idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.1 (2009): 276. Web. 23 Oct. 2019.

  23. Spruit, M. A.

    1. Graat-Verboom, L. et al "Current status of research on osteoporosis in COPD: a systematic review." European Respiratory Journal 34.1 (2009): 209-218. Web. 23 Oct. 2019.

  24. Stoufflet, A.

    1. Paris, C. et al "Pleural plaques and asbestosis: dose– and time–response relationships based on HRCT data." European Respiratory Journal 34.1 (2009): 72-79. Web. 23 Oct. 2019.

  25. Strazda, G.

    1. Isajevs, S. et al " From the authors: ." European Respiratory Journal 34.1 (2009): 285-286. Web. 23 Oct. 2019.

  26. Suc, B.

    1. Degano, B. et al "Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients." European Respiratory Journal 34.1 (2009): 138-144. Web. 23 Oct. 2019.

  27. Suissa, S.

    1. Suissa, S., and P. J. Barnes. "Inhaled corticosteroids in COPD: the case against." European Respiratory Journal 34.1 (2009): 13-16. Web. 23 Oct. 2019.

  28. Sundblad, B-M.

    1. Sundblad, B-M. et al "Repeated exposure to organic material alters inflammatory and physiological airway responses." European Respiratory Journal 34.1 (2009): 80-88. Web. 23 Oct. 2019.

  29. Swanson, N.

    1. Wang, Z. et al "Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?." European Respiratory Journal 34.1 (2009): 145-155. Web. 23 Oct. 2019.

  30. Swedin, L.

    1. Swedin, L. et al "Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice." European Respiratory Journal 34.1 (2009): 200-208. Web. 23 Oct. 2019.

T

  1. Taivans, I.

    1. Isajevs, S. et al " From the authors: ." European Respiratory Journal 34.1 (2009): 285-286. Web. 23 Oct. 2019.

  2. Takahashi, T.

    1. Ohta, K. et al "Evaluation of swallowing function by two screening tests in primary COPD." European Respiratory Journal 34.1 (2009): 280-281. Web. 23 Oct. 2019.

  3. Tal-Singer, R.

    1. Lomas, D. A. et al "Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD." European Respiratory Journal 34.1 (2009): 95-102. Web. 23 Oct. 2019.

  4. Tankersley, C.

    1. Hansel, N. N. et al "Leptin receptor polymorphisms and lung function decline in COPD." European Respiratory Journal 34.1 (2009): 103-110. Web. 23 Oct. 2019.

  5. Teo, S. S. S.

    1. Teo, S. S. S. et al "An evaluation of the completeness of reporting of childhood tuberculosis." European Respiratory Journal 34.1 (2009): 176-179. Web. 23 Oct. 2019.

  6. Teran, J.

    1. Masa, J. F. et al "Apnoeic and obstructive nonapnoeic sleep respiratory events." European Respiratory Journal 34.1 (2009): 156-161. Web. 23 Oct. 2019.

  7. Thierry, S.

    1. Paris, C. et al "Pleural plaques and asbestosis: dose– and time–response relationships based on HRCT data." European Respiratory Journal 34.1 (2009): 72-79. Web. 23 Oct. 2019.

  8. Timens, W.

    1. Brusselle, G. G. et al "Lymphoid follicles in (very) severe COPD: beneficial or harmful?." European Respiratory Journal 34.1 (2009): 219-230. Web. 23 Oct. 2019.

  9. Trinquart, L.

    1. Hubert, D. et al "Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments." European Respiratory Journal 34.1 (2009): 117-124. Web. 23 Oct. 2019.

  10. Turnbull, K.

    1. Murray, M. P. et al "Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis." European Respiratory Journal 34.1 (2009): 125-131. Web. 23 Oct. 2019.

V

  1. van den Borne, B. E. E. M.

    1. Graat-Verboom, L. et al "Current status of research on osteoporosis in COPD: a systematic review." European Respiratory Journal 34.1 (2009): 209-218. Web. 23 Oct. 2019.

  2. van Hage, M.

    1. Swedin, L. et al "Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice." European Respiratory Journal 34.1 (2009): 200-208. Web. 23 Oct. 2019.

  3. Varela, G.

    1. Brunelli, A. et al "ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)." European Respiratory Journal 34.1 (2009): 17-41. Web. 23 Oct. 2019.

  4. Vestbo, J.

    1. Plumb, J. et al "Increased T-regulatory cells within lymphocyte follicles in moderate COPD." European Respiratory Journal 34.1 (2009): 89-94. Web. 23 Oct. 2019.

  5. Volders, H. H.

    1. Maarsingh, H. et al "l-Arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction." European Respiratory Journal 34.1 (2009): 191-199. Web. 23 Oct. 2019.

  6. Völzke, H.

    1. Koch, B. et al " From the authors: ." European Respiratory Journal 34.1 (2009): 287-288. Web. 23 Oct. 2019.

  7. von Scheele, I.

    1. Sundblad, B-M. et al "Repeated exposure to organic material alters inflammatory and physiological airway responses." European Respiratory Journal 34.1 (2009): 80-88. Web. 23 Oct. 2019.

W

  1. Wang, Z.

    1. Wang, Z. et al "Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?." European Respiratory Journal 34.1 (2009): 145-155. Web. 23 Oct. 2019.

  2. Watanabe, K.

    1. Harada, T. et al "Histological findings of the computed tomography halo in pulmonary sarcoidosis." European Respiratory Journal 34.1 (2009): 281-283. Web. 23 Oct. 2019.

  3. Watson, J. M.

    1. Teo, S. S. S. et al "An evaluation of the completeness of reporting of childhood tuberculosis." European Respiratory Journal 34.1 (2009): 176-179. Web. 23 Oct. 2019.

  4. White, K. L.

    1. Lockey, J. E. et al "Airway obstruction related to diacetyl exposure at microwave popcorn production facilities." European Respiratory Journal 34.1 (2009): 63-71. Web. 23 Oct. 2019.

  5. Williamson, J. P.

    1. Williamson, J. P. et al "Quantifying tracheobronchial tree dimensions: methods, limitations and emerging techniques." European Respiratory Journal 34.1 (2009): 42-55. Web. 23 Oct. 2019.

  6. Win, T.

    1. Brunelli, A. et al "ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)." European Respiratory Journal 34.1 (2009): 17-41. Web. 23 Oct. 2019.

  7. Winkler, J.

    1. Hoeper, M. M. et al "Long-term outcome with intravenous iloprost in pulmonary arterial hypertension." European Respiratory Journal 34.1 (2009): 132-137. Web. 23 Oct. 2019.

  8. Wise, R. A.

    1. Hansel, N. N. et al "Leptin receptor polymorphisms and lung function decline in COPD." European Respiratory Journal 34.1 (2009): 103-110. Web. 23 Oct. 2019.

  9. Wouters, E. F. M.

    1. Graat-Verboom, L. et al "Current status of research on osteoporosis in COPD: a systematic review." European Respiratory Journal 34.1 (2009): 209-218. Web. 23 Oct. 2019.

  10. Wu, Y-B.

    1. Liu, G-N. et al "Epithelial neutrophil-activating peptide-78 recruits neutrophils into pleural effusion." European Respiratory Journal 34.1 (2009): 184-190. Web. 23 Oct. 2019.

X

  1. Xie, Z-H.

    1. Liu, G-N. et al "Epithelial neutrophil-activating peptide-78 recruits neutrophils into pleural effusion." European Respiratory Journal 34.1 (2009): 184-190. Web. 23 Oct. 2019.

Z

  1. Zaagsma, J.

    1. Maarsingh, H. et al "l-Arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction." European Respiratory Journal 34.1 (2009): 191-199. Web. 23 Oct. 2019.

  2. Zaleskis, R.

    1. Dravniece, G. et al "Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis." European Respiratory Journal 34.1 (2009): 180-183. Web. 23 Oct. 2019.

  3. Zamorano, J.

    1. Masa, J. F. et al "Apnoeic and obstructive nonapnoeic sleep respiratory events." European Respiratory Journal 34.1 (2009): 156-161. Web. 23 Oct. 2019.

  4. Zhan, Y.

    1. Jackaman, C. et al "Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells." European Respiratory Journal 34.1 (2009): 162-175. Web. 23 Oct. 2019.
Back to top
European Respiratory Journal: 34 (1)

Search Within This Issue

Jump to

Manage Table of content Alerts